Advertisement

ASC News

Pacira Pharmaceuticals reached an amicable resolution with the United States in a lawsuit filed earlier this year. The resolution confirms the company's bupivacaine liposome injectable suspension product Exparel is broadly indicated for surgical site administration for postsurgical analgesia, but isn't…

Advertisement

The U.S. Census Bureau's Quarterly Services reported healthcare spending increased 5.6 percent in the third quarter, as opposed to the same period the year prior, according to California Healthline.

Advertisement